Andreja C Belcic

Title: Andreja C Belcic: Innovator in Pharmaceutical Chemistry

Introduction

Andreja C Belcic is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. His work has implications for the treatment of gastrointestinal disorders, showcasing the importance of innovation in healthcare.

Latest Patents

Belcic holds a patent for a crystalline form of omeprazole, specifically referred to as omeprazole form C. This patent discloses a novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole. The patent also details a process for the preparation of omeprazole form C, a pharmaceutical formulation containing this form in admixture with pharmaceutically acceptable excipients, and its use for treating gastrointestinal disorders. He has 1 patent to his name.

Career Highlights

Belcic is currently employed at Lek Pharmaceuticals D.d., a prominent pharmaceutical company in Slovenia. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation and delivery.

Collaborations

Throughout his career, Belcic has collaborated with several professionals in the field, including Natasa H Milac and Anton Copar. These collaborations have fostered a productive environment for innovation and advancement in pharmaceutical research.

Conclusion

Andreja C Belcic's contributions to pharmaceutical chemistry, particularly through his patent on omeprazole form C, highlight the critical role of inventors in advancing medical science. His work at Lek Pharmaceuticals D.d. and collaborations with other professionals further emphasize the importance of teamwork in driving innovation.